Carregant...

Update in the medical therapy of Cushing’s disease

PURPOSE OF REVIEW: Recently developed agents treat Cushing’s disease by inhibiting adrenocorticotropic hormone (ACTH) secretion from corticotrope tumors or antagonizing cortisol action. RECENT FINDINGS: The dopamine agonist cabergoline and the somatostatin agonist pasireotide target ACTH secretion....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Nieman, Lynnette K.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4215263/
https://ncbi.nlm.nih.gov/pubmed/23807605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0b013e3283631809
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!